论文期刊

取消

高级检索

检索历史清除

首页> Blood cancer journal> Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry.

Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry.

导出 OA

翻译打印收藏纠错

作者： Sikander,Ailawadhi ^[1] ; Hans C,Lee ^[2] ; James,Omel ^[3] ; Kathleen,Toomey ^[4] ; James W,Hardin ^[5] ; Cristina J,Gasparetto ^[6] ; Sundar,Jagannath ^[7] ; Robert M,Rifkin ^[8] ; Brian G M,Durie ^[9] ; Mohit,Narang ^[10] ; Howard R,Terebelo ^[11] ; Prashant,Joshi ^[12] ; Ying-Ming,Jou ^[12] ; Jorge,Mouro ^[12] ; Edward,Yu ^[12] ; Rafat,Abonour ^[13]

作者单位： Mayo Clinic, Jacksonville, FL, USA. ailawadhi.sikander@mayo.edu. ^[1] The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ^[2] Myeloma Research Advocate/Advisor, Grand Island, NE, USA. ^[3] Steeplechase Cancer Center, Somerville, NJ, USA. ^[4] University of South Carolina, Columbia, SC, USA. ^[5] Duke University Medical Center, Durham, NC, USA. ^[6] Mount Sinai Hospital, New York, NY, USA. ^[7] Rocky Mountain Cancer Centers US Oncology, Denver, CO, USA. ^[8] Cedars-Sinai Medical Center, Los Angeles, CA, USA. ^[9] US Oncology Research, Columbia, MD, USA. ^[10] Providence Cancer Institute, Southfield, MI, USA. ^[11] Bristol Myers Squibb, Princeton, NJ, USA. ^[12] Indiana University, Indianapolis, IN, USA. ^[13]

主题词成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);地塞米松(Dexamethasone);多发性骨髓瘤(Multiple Myeloma);登记(Registries);肾功能不全(Renal Insufficiency)

DOI 10.1038/s41408-024-01177-6

PMID 39528478

发布时间 2024-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Blood cancer journal

Blood cancer journal

2024年14卷1期

198页

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷